| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/2014 | WO2014111811A1 Veterinary supplements |
| 07/24/2014 | WO2014111751A1 Use of alpha 7 nicotinic receptor agonists for the treatment of narcolepsy |
| 07/24/2014 | WO2014111737A1 Composition for increasing of the effectiveness of uv-b therapy, process for the preparation thereof, and its use |
| 07/24/2014 | WO2014111720A1 Crystalline form of vsn16 |
| 07/24/2014 | WO2014111584A1 Methods of treatment of fibrosis and cancers |
| 07/24/2014 | WO2014111580A1 Urolithin b for muscle growth |
| 07/24/2014 | WO2014111525A2 New combination therapies for treating nervous system diseases |
| 07/24/2014 | WO2014111496A1 3-substituted pyrazoles and use as dlk inhibitors |
| 07/24/2014 | WO2014111465A1 Isomannide derivatives as inhibitors of soluble epoxide hydrolase |
| 07/24/2014 | WO2014111457A1 Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators |
| 07/24/2014 | WO2014111380A1 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 07/24/2014 | WO2014111356A1 Oxytocin receptor agonists for the treatment of cns diseases |
| 07/24/2014 | WO2014111268A1 Oral combination for the prevention and treatment of bladder, pelvic and urogenital apparatus pathologies |
| 07/24/2014 | WO2014111069A1 Helquat derivatives, preparation thereof, and use thereof as medicaments |
| 07/24/2014 | WO2014110706A1 Thiophene-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases |
| 07/24/2014 | WO2014110705A1 Heterocycle-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases |
| 07/24/2014 | WO2014110688A1 Thiophene- sub stitued tetracyclic compounds and methods of use thereof for the treatment of viral diseases |
| 07/24/2014 | WO2014110687A1 Thiazolyl-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases |
| 07/24/2014 | WO2014089177A3 Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines |
| 07/24/2014 | WO2014085453A3 Small molecule lxr inverse agonists |
| 07/24/2014 | WO2014083567A3 Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors |
| 07/24/2014 | WO2014081856A3 Ligands that target hcv-e2 binding sites on cd81 and therapeutic methods using them |
| 07/24/2014 | WO2014076713A3 Crystalline bortezomib process |
| 07/24/2014 | WO2014076568A3 Pharmaceutical compositions of cetp inhibitors |
| 07/24/2014 | WO2014068516A3 A method of managing urolithiasis and related urological disorders |
| 07/24/2014 | WO2014057432A3 Multicomponent lipid nanoparticles and processes for the preparation thereof |
| 07/24/2014 | WO2014052739A8 System for interactively visualizing and evaluating user behavior and output |
| 07/24/2014 | WO2013167088A3 Synthesis method for l-cyclic alkyl amino acid and pharmaceutical composition having said acid |
| 07/24/2014 | WO2013103919A8 Compositions and methods for treating metabolic disorders |
| 07/24/2014 | WO2013006795A3 Antiviral compositions and methods of their use |
| 07/24/2014 | US20140206865 Human Adam-10 Inhibitors |
| 07/24/2014 | US20140206861 Antioxidant Small Molecules Aimed at Targeting Metal-Based Oxidative Stress in Neurodegenerative Disorders |
| 07/24/2014 | US20140206771 Liquid pharmaceutical composition comprising nitisinone |
| 07/24/2014 | US20140206770 Androgen receptor-dependent gene expression control |
| 07/24/2014 | US20140206769 Nitroxyl donors with improved therapeutic index |
| 07/24/2014 | US20140206766 Prostaglandin compositions and methods for the treatment of vasospasm |
| 07/24/2014 | US20140206765 Acetylcysteine Compositions and Methods of use Thereof |
| 07/24/2014 | US20140206764 Poly(Nitrogen/Amine) Derivatives of a Natural Wax and Ophthalmic Compositions |
| 07/24/2014 | US20140206763 Phenylbutyrate for treatment of sporadic inclusion-body myositis and disorders relating to autophagy impairment or amyloid beta 42 accumulation |
| 07/24/2014 | US20140206762 Compositions And Methods Of Use Of Phorbol Esters |
| 07/24/2014 | US20140206761 Process for preparing hydroxylamines and medicaments |
| 07/24/2014 | US20140206759 Process for the production of biodegradeable, functionalised polymer particles, and use thereof as pharmaceutical supports |
| 07/24/2014 | US20140206757 Treatment of cancer |
| 07/24/2014 | US20140206751 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules |
| 07/24/2014 | US20140206749 Targeting the Steroidogenic Pathway For Treating and/or Preventing Allergic Diseases |
| 07/24/2014 | US20140206745 Methods for modulating kallikrein (klkb1) expression |
| 07/24/2014 | US20140206743 Use of 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methylpropyl]amino-3,4-dihydro- 2h-1,5-benzoxathiepine for treating cancer and in particular for preventing and/or treating cancer metastases |
| 07/24/2014 | US20140206742 Pharmaceutical composition with improved bioavailability |
| 07/24/2014 | US20140206740 Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters |
| 07/24/2014 | US20140206736 Compositions comprising amino acids for prevention and/or treatment of renal disorders |
| 07/24/2014 | US20140206735 High dosage topical metronidazole aqueous-based gel formulations and their use to treat rosacea |
| 07/24/2014 | US20140206734 Serotonin transporter gene and treatment of alcoholism |
| 07/24/2014 | US20140206733 Liquid Formulations Of Bendamustine |
| 07/24/2014 | US20140206732 Compositions and Methods of Treatment of Inflammatory Skin Conditions Using Allantoin |
| 07/24/2014 | US20140206729 Amorphous mirabegron and processes for crystal forms of mirabegron |
| 07/24/2014 | US20140206728 Durable treatment with 4-aminopyridine in patients with demyelination |
| 07/24/2014 | US20140206724 Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent |
| 07/24/2014 | US20140206723 Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione |
| 07/24/2014 | US20140206721 Method to predict response to pharmacological chaperone treatment of diseases |
| 07/24/2014 | US20140206720 Dosage units of 3-(6-(1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 07/24/2014 | US20140206719 Crystal form of quinoline compound and process for its production |
| 07/24/2014 | US20140206718 Method of enhancing lysosomal alpha-Galactosidase A |
| 07/24/2014 | US20140206717 Use of inorganic matrix and organic polymer combinations for preparing stable amorphous dispersions |
| 07/24/2014 | US20140206716 Methods and compositions for the assessment of drug response |
| 07/24/2014 | US20140206710 Compound ambroxol hydrochloride composition and its preparation method |
| 07/24/2014 | US20140206708 Composition for ophthalmic administration |
| 07/24/2014 | US20140206706 Five-membered heterocycles useful as serine protease inhibitors |
| 07/24/2014 | US20140206704 Starch-based microparticles for the release of agents disposed therein |
| 07/24/2014 | US20140206700 Chemical compounds |
| 07/24/2014 | US20140206698 Methods of Diagnosing Diastolic Dysfunction |
| 07/24/2014 | US20140206695 Renal function with quercetin-containing compositions |
| 07/24/2014 | US20140206693 Compositions and methods for treating colon cancer |
| 07/24/2014 | US20140206692 Oral formulations of kinase inhibitors |
| 07/24/2014 | US20140206691 Cyclic protein tyrosine kinase inhibitors |
| 07/24/2014 | US20140206689 Modulators of atp-binding cassette transporters |
| 07/24/2014 | US20140206681 Btk inhibitors |
| 07/24/2014 | US20140206680 Substituted 6-aza-isoindolin-1-one derivatives |
| 07/24/2014 | US20140206678 Inhibitors of mtor kinase as anti -viral agent |
| 07/24/2014 | US20140206676 Substituted 4-(1h-pyrazol-4-yl)benzyl analogues as positive allosteric modulators of machr m1 receptors |
| 07/24/2014 | US20140206674 Combinations with 2-aminoethanesulfonic acid |
| 07/24/2014 | US20140206673 Therapeutically active compositions and their methods of use |
| 07/24/2014 | US20140206670 Combinations comprising alpha-2-delta ligands |
| 07/24/2014 | US20140206667 Methods and compositions for treating schizophrenia |
| 07/24/2014 | US20140206661 Thiadiazole analogs thereof and methods for treating smn-deficiency-related-conditions |
| 07/24/2014 | US20140206659 Tazobactam arginine antibiotic compositions |
| 07/24/2014 | US20140206656 Methods of providing anti-inflammation support |
| 07/24/2014 | US20140206654 Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ |
| 07/24/2014 | US20140206653 [Cu(thp)4]n[X]-n Compounds For The Treatment Of A Broad Range Of Human Solid Tumors, Including Refractory Tumors |
| 07/24/2014 | US20140206649 Cannabinoid receptor modulators |
| 07/24/2014 | US20140206648 Heterocyclic boronic acid ester derivatives and therapeutic uses thereof |
| 07/24/2014 | US20140206644 Methods and compositions for inhibiting cellular proliferation and surgical adhesion |
| 07/24/2014 | US20140206642 Methods of use of biomaterial and injectable implant containing biomaterial |
| 07/24/2014 | US20140206641 Remedy |
| 07/24/2014 | US20140206640 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
| 07/24/2014 | US20140206639 Uses of dihydro bases |
| 07/24/2014 | US20140206638 Pulmonary delivery of aminoglycoside |
| 07/24/2014 | US20140206637 Inhibition of Nonsense Mediated mRNA Decay by Drugs that Prevent Hypusination of Eukaryotic Initiation Factor 5A |
| 07/24/2014 | US20140206636 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 07/24/2014 | US20140206635 Metal-salen complex compound, local anesthetic and antineoplastic drug |
| 07/24/2014 | US20140206634 Natural Composition to Decrease Effects of a High Fat Diet |